Two new anticoagulants just hit the market
July 1997
Two new anticoagulants just hit the market...Normiflo (ardeparin) and Orgaran (danaparoid). They're both approved to prevent deep vein thrombosis after certain orthopedic surgeries.
Normiflo is a low molecular weight heparin...similar to Lovenox (enoxaparin) and Fragmin (dalteparin).
Low molecular weight heparins contain heparin fragments. They work at least as well as heparin...with less risk of bleeding.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote